Musculoskeletal Transplant Foundation Inc

MTF IS A NONPROFIT ORG. THAT SAVES AND HEALS LIVES BY HONORING DONATED GIFTS AND SERVING PATIENTS, WE COLLABORATE WITH THE MEDICAL, SCIENTIFIC, AS WELL AS ORGAN AND TISSUE DONATION COMMUNITIES. CONTINUED ON SCHEDULE O.

MTF PROVIDES ALLOGRAFT TISSUES TO THE MEDICAL COMMUNITY. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 150,000 DONORS. IN 2021, MTF RECOVERED TISSUE FROM OVER 5,500 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 7,000 DONORS FOR USE IN BURN, GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 1,400 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 900 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED APPROXIMATELY 400,000 UNITS OF ALLOGRAFT TISSUE DURING 2021. IN 2021 MTF PERSEVERED THROUGH THE CHALLENGES FACED IN 2020. MTF CONTINUED TO DEVELOP INNOVATIVE TISSUE FORMS, FOCUSED ON SOLVING REAL-WORLD, CLINICAL PROBLEMS. MTF HAS ALSO CONTINUED ITS EFFORTS TO PROVIDE SPECIAL RESEARCH TISSUE FOR RESEARCH PERFORMED BY MEMBERS OF THE ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE, AN ORGANIZATION DEDICATED TO DEVELOPING MEDICAL THERAPIES FOR WOUNDED SOLDIERS. MTF CONTINUED ITS MISSION TO MAKE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS. MTF'S ORTHOPEDIC FRANCHISE CONTINUED GROWTH, DESPITE A CONTINUED GLOBAL IMPACT BY THE COVID-19 PANDEMIC. NEW AND INNOVATIVE TISSUE FORMS DROVE THE GROWTH IN 2021, AS WELL AS NEW PARTNERSHIPS IN THE DISTRIBUTION OF HUMAN ALLOGRAFT TISSUE FORMS. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY FRANCHISE, MTF WAS ABLE TO GROW THROUGH SUCCESSFUL CONTRACT ASSOCIATIONS. MTF CONTINUED TO DEVELOP AND MAINTAIN ITS STRATEGIC INTER-INDUSTRY PARTNERSHIPS INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND INCREASING PROCESSING CAPACITY, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE DIVISION WAS ABLE TO GROW THROUGHOUT 2021, DESPITE CONTINUED PANDEMIC IMPACT TO SURGEONS AND PATIENTS. MTF CONTINUED ITS CLINICAL STUDY PORTFOLIO, INCREASING ITS COMPENDIUM OF CLINICAL DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY OF ITS TISSUE FORMS. MTF CONTINUED ITS SUPPORT OF THE AMERICAN SOCIETY OF PLASTIC SURGEONS ASPS) AND THE PLASTIC SURGERY FOUNDATION (PSF) WHICH PROVIDES OPPORTUNITIES FOR SURGEONS TO PERFORM ALLOGRAFT BASED RESEARCH TO ADVANCE THE SCIENCE OF ALLOGRAFT USE IN PLASTIC/RECONSTRUCTIVE PROCEDURES. MTF ALSO REMAINS COMMITTED TO SUPPORTING BREAST RECONSTRUCTION AWARENESS (BRA)DAY EACH YEAR AND INCLUDES EDUCATION FOR BOTH PATIENTS AND SURGEONS ON THE OPTIONS AVAILABLE TODAY FOR WOMEN, HELPING TO ENSURE SURVIVORS' RIGHTS TO MAKE AN INFORMED DECISION. MTF ALSO CONTINUED ITS FINANCIAL PLEDGE OF (1MIL OVER FIVE YEARS) TO SUPPORT BIOLOGIC RESEARCH THROUGH THE PLASTIC SURGERY FOUNDATION (PSF). MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS.